Expect decision regarding the advancement of an Aβ oligomer-targeted Enhanced Brain DeliveryTM product candidate in early 2026Expect to report ...

DALLAS, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its ...

All sectors in the Russell 1000 Value were in the positive save for Consumer Staples. Portfolio stock selection was a ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the third quarter ...

Highlights for the third quarter of 2025 included the following: ...

Self-serve revenue grew 33% year over year in Q3, comprising about 60% of total revenue. Adjusted EBITDA -- $4 million in ...

Edgewise Therapeutics Inc. (Nasdaq: EWTX), a Boulder-based biopharmaceutical company that develops therapies for muscle disease, reported a higher net loss for the third quarter.

BOCA RATON, FL / ACCESS Newswire / November 13, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced ...

Equinix is the most prominent colocation data center provider in the industry having developed the most widespread network of ...

Q3 2025 Management View Masoud Toloue, President and CEO, stated that "we're pleased with how we executed in the third ...

Q3 2025 Management View CEO Christian Itin reported the launch of AUCATZYL in the U.S. has reached market leadership in ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower on Friday. The company released its third-quarter financial ...